Donald Sheppard
7Patents
2h-index
17Co-inventors
48Inventor score
Filing activity: Nov 18, 2000 → Dec 8, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8541008B2 | Pharmaceutical compositions and methods to vaccinate against candidiasis | Human Necessities | 6 | Expired |
| US7067138B1 | Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis | Emerging Cross-Sectional Technologies | 5 | Expired |
| US10905749B2 | Soluble bacterial and fungal proteins and methods and uses thereof in inhibiting and dispersing biofilm | Emerging Cross-Sectional Technologies | 1 | Active |
| US11230594B2 | Anti-galactofuranose antibodies for detecting and treating aspergillosis | Emerging Cross-Sectional Technologies | 0 | Active |
| US11672846B2 | Soluble bacterial and fungal proteins and methods and uses thereof in inhibiting and dispersing biofilm | Emerging Cross-Sectional Technologies | 0 | Active |
| US9364539B2 | Pharmaceutical compositions and methods to vaccinate against candidiasis | Human Necessities | 0 | Active |
| US12269868B2 | Anti-galactofuranose antibodies for detecting and treating aspergillosis | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.